Delivery Order SPE2DB24D2205-SPE2DB25FDWNM

Award Date 1/6/25
Potential Completion Date 1/28/25
Potential Value $5.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,773.26 fixed-price contract is for the delivery of SOMATULINE DEPOT 90 MG/0.3 ML 0.3ML, a specialty pharmaceutical product. The contract has an ultimate completion date of May 16, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The $2,896.41 firm-fixed price delivery order is for the supply of SOMATULINE DEPOT 120 MG/0.5 ML 0.5ML, a specialty medication. The contract has a completion date of July 23, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of SOMATULINE DEPOT 90 MG/0.3 ML 0.3ML. The contract has a ceiling value of $21,546.52 and is a Firm Fixed Price contract type. The contract is not designated with any set-aside requirements, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $39,315.57, is for the supply of SOMATULINE DEPOT 90 MG/0.3 ML 0.3ML, a specialty pharmaceutical product. The contract has an ultimate completion date of March 3, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The contract is a Delivery Order valued at $17,378.46 for the supply of SOMATULINE DEPOT 120 MG/0.5 ML 0.5ML, a pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of June 25, 2024. Amerisourcebergen, a major pharmaceutical distribution company, has an Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $19,759.30 fixed-price delivery order is for the supply of SOMATULINE DEPOT 120 MG/0.5 ML 0.5ML, a specialty medication. The contract has an ultimate completion date of February 11, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This contract award to Amerisourcebergen Drug Corp is a Delivery Order under the company's existing Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 through November 2026. The awarded Delivery Order, valued at $4,611.84, is for the pharmaceutical product Somatuline Depot 90 mg/0.3 mL 0.3mL. This contract has no set-aside designation, indicating open competition. Amerisourcebergen, a major pharmaceutical distributor and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,686.67, is for the delivery of SOMATULINE DEPOT 90 MG/0.3 ML 0.3ML, a specialty pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of June 3, 2024. This award is not designated as a set-aside contract. AmerisourceBergen holds a...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4564433789 - SOMATULINE DEPOT 90 MG/0.3 ML 0.3ML pharmaceutical product. The contract has a ceiling value of $2,228.89 and an ultimate completion date of May 20, 2024. This contract is not set aside and is a Firm Fixed Price agreement. Amerisourcebergen Drug Corp's Corporate Office Division is the prime contractor, and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,228.89 fixed-price delivery order is for the supply of Somatuline Depot, a specialty medication used for the treatment of certain medical conditions. The contract has a completion date of November 19, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB25FDWNM
    Delivery Order

This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of SOMATULINE DEPOT 90 MG/0.3 ML 0.3ML, a specialty medication, to support federal healthcare programs. The contract has a ceiling value of $5,616.51 and a completion date of January 28, 2025.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries through a streamlined, comprehensive contracting mechanism.

Generated 4/7/25, 10:42 AM